Familial Mediterranean fever: An updated review

İsmail SARI, (Dokuz Eylül Üniversitesi, Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Romatoloji Bilim Dalı, İzmir, Türkiye)
AHMET MERİH BİRLİK, (Dokuz Eylül Üniversitesi, Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Romatoloji Bilim Dalı, İzmir, Türkiye)
Timuçin KAŞİFOĞLU (Eskişehir Osmangazi Üniversitesi Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Romatoloji Bilim Dalı, Eskişehir, Türkiye)
European Journal of Rheumatology
10 2
Yıl: 2014 Cilt: 1 Sayı: 1 Sayfa Aralığı: 21 - 33 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Familial Mediterranean fever: An updated review

Öz:
Ailevi Akdeniz ateşi (AAA) akut ateş atakları ve serozal inflamasyonla karakterize kalıtsal otoinflamatuvar bir bozukluktur. AAA öncelikle Yahudi, Ermeni, Türk ve Arap popülasyonlarını etkiler. Hastalığa atakların ve ataksız dönemlerdeki subklinik inflamasyonun etkileri nedeniyle oluşan yaşam kalitesindeki belirgin düşüş eşlik eder. Tedavi edilmemiş veya yetersiz tedavi edilmiş hastalar morbiditenin ve mortalitenin önemli bir nedeni olan amiloidoz riski taşır. Bu derlemede, AAA üzerine mevcut bilgiler özetlendi.
Anahtar Kelime:

Konular: Romatoloji

Ailevi Akdeniz Ateşi: Güncellenmiş derleme

Öz:
Familial Mediterranean Fever (FMF) is a hereditary autoinflammatory disorder characterised by acute attacks of fever and serosal inflammation. FMF primarily affects Jewish, Armenian, Turkish, and Arab populations. The disease is accompanied by a marked decrease in quality of life due to the effects of attacks and subclinical inflammation in the attack-free periods. Untreated or inadequately treated patients run the risk of amyloidosis, which is an important cause of morbidity and mortality. In this review, the current information available on FMF is summarised
Anahtar Kelime:

Konular: Romatoloji
Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık
  • Onen F. Familial Mediterranean fever. Rheuma- tol Int 2006; 26: 489-96. [CrossRef]
  • Sohar E, Gafni J, Pras M, Heller H. Familial Med- iterranean fever. A survey of 470 cases and re- view of the literature. Am J Med 1967; 43: 227- 53. [CrossRef] 3. Livneh A, Langevitz P, Zemer D, Padeh S, Migdal A, Sohar E, et al. The changing face of familial Mediterranean fever. Semin Arthritis Rheum 1996; 26: 612-27.[CrossRef]
  • Mehmet T. Ailevi Akdeniz ateşinin tarihçesi Dünya'da ve Türkiye'de ailevi Akdeniz ateşi. Türkiye Klinikleri Dahili Tıp Bilimleri İmmünoloji Romatoloji 2006; 2: 4-8.
  • French FMF Consortium. A candidate gene for familial Mediterranean fever. Nat Genet 1997; 17: 25-31. [CrossRef]
  • The International FMF Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 1997; 90: 797-807.
  • Ozcakar ZB, Yalcinkaya F, Yuksel S, Acar B, Gok- men D, Ekim M. Possible effect of subclinical inflammation on daily life in familial Mediter- ranean fever. Clin Rheumatol 2006; 25: 149-52. [CrossRef]
  • Cakir N, Pamuk ON, Dervis E, Imeryuz N, Uslu H, Benian O, et al. The prevalences of some rheu- matic diseases in western Turkey: Havsa study. Rheumatol Int 2012; 32: 895-908.
  • Cobankara V, Fidan G, Turk T, Zencir M, Colakog- lu M, Ozen S. The prevalence of familial Mediter- ranean fever in the Turkish province of Denizli: a field study with a zero patient design. Clin Exp Rheumatol 2004; 22: S27-30.
  • Kisacik B, Yildirim B, Tasliyurt T, Ozyurt H, Ozyurt B, Yuce S, et al. Increased frequency of familial Mediterranean fever in northern Turkey: a pop- ulation-based study. Rheumatol Int 2009; 29: 1307-9. [CrossRef]
  • Onen F, Sumer H, Turkay S, Akyurek O, Tunca M, Ozdogan H. Increased frequency of familial Mediterranean fever in Central Anatolia, Turkey. Clin Exp Rheumatol 2004; 22: S31-3.
  • Ozdogan H, Ugurlu S, Hatemi G, Demirel Y, Calli S, Ozgon G, et al. Prevalence of FMF and Chronic Renal Failure due to Amyloidosis and Frequency of MEFV Mutations in Zara, Turkey. EULAR. London; 2011.
  • Ozen S, Karaaslan Y, Ozdemir O, Saatci U, Bakka- loglu A, Koroglu E, et al. Prevalence of juvenile chronic arthritis and familial Mediterranean fe- ver in Turkey: a field study. J Rheumatol 1998; 25: 2445-9.
  • Sarkisian T, Ajrapetian H, Beglarian A, Shahsu- varian G, Egiazarian A. Familial Mediterranean Fever in Armenian population. Georgian Med News 2008: 105-11.
  • Samuels J, Aksentijevich I, Torosyan Y, Centola M, Deng Z, Sood R, et al. Familial Mediterranean fe- ver at the millennium. Clinical spectrum, ancient mutations, and a survey of 100 American refer- rals to the National Institutes of Health. Medicine (Baltimore) 1998; 77: 268-97. [CrossRef]
  • Ben-Chetrit E, Touitou I. Familial mediterranean Fever in the world. Arthritis Rheum 2009; 61: 1447-53. [CrossRef]
  • Deltas CC, Mean R, Rossou E, Costi C, Koupepi- dou P, Hadjiyanni I, et al. Familial Mediterranean fever (FMF) mutations occur frequently in the Greek-Cypriot population of Cyprus. Genet Test 2002; 6: 15-21. [CrossRef]
  • La Regina M, Nucera G, Diaco M, Procopio A, Gasbarrini G, Notarnicola C, et al. Familial Medi- terranean fever is no longer a rare disease in It- aly. Eur J Hum Genet 2003; 11: 50-6. [CrossRef]
  • Jesus AA, Fujihira E, Watase M, Terreri MT, Hilario MO, Carneiro-Sampaio M, et al. Hereditary au- toinflammatory syndromes: a Brazilian multi- center study. J Clin Immunol 2012; 32: 922-32. [CrossRef]
  • Toplak N, Dolezalova P, Constantin T, Sediva A, Pasic S, Ciznar P, et al. Periodic fever syndromes in Eastern and Central European countries: re- sults of a pediatric multinational survey. Pediatr Rheumatol Online J 2010; 8: 29. [CrossRef]
  • Migita K, Uehara R, Nakamura Y, Yasunami M, Tsuchiya-Suzuki A, Yazaki M, et al. Familial Med- iterranean fever in Japan. Medicine (Baltimore) 2012; 91: 337-43. [CrossRef]
  • Ozkurede VU, Franchi L. Immunology in clinic review series; focus on autoinflammatory diseas- es: role of inflammasomes in autoinflammatory syndromes. Clin Exp Immunol 2012; 167: 382-90. [CrossRef]
  • Gattorno M, Galeotti C, Caorsi R, Hentgen V. Au- toinflammatory syndromes. In: Bijlsma JWJ, ed. EULAR Textbook on Rheumatic Diseases 2012. p. 372-89.
  • Gross O, Thomas CJ, Guarda G, Tschopp J. The inflammasome: an integrated view. Immunol Rev 2011; 243: 136-51. [CrossRef]
  • Mankan AK, Kubarenko A, Hornung V. Immu- nology in clinic review series; focus on autoin- flammatory diseases: inflammasomes: mech- anisms of activation. Clin Exp Immunol 2012; 167: 369-81. [CrossRef]
  • Cantarini L, Rigante D, Brizi MG, Lucherini OM, Sebastiani GD, Vitale A, et al. Clinical and bio- chemical landmarks in systemic autoinflam- matory diseases. Ann Med 2012; 44: 664-73. [CrossRef]
  • Chae JJ, Aksentijevich I, Kastner DL. Advances in the understanding of familial Mediterranean fever and possibilities for targeted therapy. Br J Haematol 2009; 146: 467-78. [CrossRef]
  • Samuels J, Ozen S. Familial Mediterranean fever and the other autoinflammatory syndromes: evaluation of the patient with recurrent fever. Curr Opin Rheumatol 2006; 18: 108-17. [CrossRef]
  • Ozen S. Changing concepts in familial Mediter- ranean fever: is it possible to have an autoso- mal-recessive disease with only one mutation? Arthritis Rheum 2009; 60: 1575-7. [CrossRef]
  • Booty MG, Chae JJ, Masters SL, Remmers EF, Barham B, Le JM, et al. Familial Mediterranean fever with a single MEFV mutation: where is the second hit? Arthritis Rheum 2009; 60: 1851-61. [CrossRef]
  • Tunca M, Akar S, Onen F, Ozdogan H, Kasapco- pur O, Yalcinkaya F, et al. Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore) 2005; 84: 1-11. [CrossRef]
  • Yilmaz E, Ozen S, Balci B, Duzova A, Topaloglu R, Besbas N, et al. Mutation frequency of Familial Mediterranean Fever and evidence for a high carrier rate in the Turkish population. Eur J Hum Genet 2001; 9: 553-5. [CrossRef]
  • Touitou I. The spectrum of Familial Mediterra- nean Fever (FMF) mutations. Eur J Hum Genet 2001; 9: 473-83. [CrossRef]
  • Yalcinkaya F, Cakar N, Misirlioglu M, Tumer N, Akar N, Tekin M, et al. Genotype-phenotype correlation in a large group of Turkish patients with familial mediterranean fever: evidence for mutation-independent amyloidosis. Rheuma- tology (Oxford) 2000; 39: 67-72. [CrossRef]
  • Kasifoglu T, Bilge SY, Sari I, Solmaz D, Senel S, Emmungil H, et al. Amyloidosis and its related factors in Turkish patients with familial Mediter- ranean fever: a multicentre study. Rheumatolo- gy (Oxford) 2013. [Epub ahead of print]
  • Dewalle M, Domingo C, Rozenbaum M, Ben-Chetrit E, Cattan D, Bernot A, et al. Pheno- type-genotype correlation in Jewish patients suffering from familial Mediterranean fever (FMF). Eur J Hum Genet 1998; 6: 95-7. [CrossRef]
  • Akpolat T, Ozkaya O, Ozen S. Homozygous M694V as a risk factor for amyloidosis in Turkish FMF patients. Gene 2012; 492: 285-9. [CrossRef]
  • Albayrak F, Selcuk NY, Odabas AR, Cetinkaya R, Pirim I. Genotype-phenotype correlation in pa- tients with familial Mediterranean fever in East Anatolia (Turkey). Genet Test Mol Biomarkers 2010; 14: 325-8. [CrossRef]
  • Shinar Y, Livneh A, Langevitz P, Zaks N, Aksenti- jevich I, Koziol DE, et al. Genotype-phenotype assessment of common genotypes among pa- tients with familial Mediterranean fever. J Rheu- matol 2000; 27: 1703-7.
  • Brik R, Shinawi M, Kepten I, Berant M, Gersho- ni-Baruch R. Familial Mediterranean fever: clini- cal and genetic characterization in a mixed pe- diatric population of Jewish and Arab patients. Pediatrics 1999; 103: e70. [CrossRef]
  • Düzova A, Özen S. Ailevi Akdeniz ateşinin kliniği ve tanısı. Türkiye Klinikleri Dahili Tıp Bilimleri İm- münoloji Romatoloji 2006; 2: 12-20.
  • Lidar M, Yaqubov M, Zaks N, Ben-Horin S, Langevitz P, Livneh A. The prodrome: a prominent yet over- looked pre-attack manifestation of familial Medi- terranean fever. J Rheumatol 2006; 33: 1089-92.
  • Kasifoglu T, Cansu DU, Korkmaz C. Frequency of abdominal surgery in patients with famil- ial Mediterranean fever. Intern Med 2009; 48: 523-6. [CrossRef]
  • Aharoni D, Hiller N, Hadas-Halpern I. Familial Mediterranean fever: abdominal imaging find- ings in 139 patients and review of the literature. Abdom Imaging 2000; 25: 297-300. [CrossRef]
  • Vural B, Canturk NZ, Esen N, Solakoglu S, Can- turk Z, Kirkali G, et al. The role of neutrophils in the formation of peritoneal adhesions. Hum Reprod 1999; 14: 49-54. [CrossRef]
  • Berkun Y, Ben-Chetrit E, Klar A. Peritoneal ad- hesions and intestinal obstructions in patients with familial Mediterranean fever--are they more frequent? Semin Arthritis Rheum 2007; 36: 316-21. [CrossRef]
  • Mor A, Gal R, Livneh A. Abdominal and diges- tive system associations of familial Mediterra- nean fever. Am J Gastroenterol 2003; 98: 2594- 604. [CrossRef]
  • Ishak GE, Khoury NJ, Birjawi GA, El-Zein YR, Naf- faa LN, Haddad MC. Imaging findings of famil- ial Mediterranean fever. Clin Imaging 2006; 30: 153-9. [CrossRef]
  • Tweezer-Zaks N, Doron-Libner A, Weiss P, Ben- Horin S, Barshack I, Lidar M, et al. Familial Medi- terranean fever and cryptogenic cirrhosis. Med- icine (Baltimore) 2007; 86: 355-62. [CrossRef]
  • Rimar D, Rosner I, Rozenbaum M, Zuckerman E. Familial Mediterranean fever: an association with non-alcoholic fatty liver disease. Clin Rheu- matol 2011; 30: 987-91. [CrossRef]
  • Brik R, Shinawi M, Kasinetz L, Gershoni-Baruch R. The musculoskeletal manifestations of famil- ial Mediterranean fever in children genetically diagnosed with the disease. Arthritis Rheum 2001; 44: 1416-9. [CrossRef]
  • Jarjour RA, Dodaki R. Arthritis patterns in familial Mediterranean fever patients and association with M694V mutation. Mol Biol Rep 2011; 38: 2033-6. [CrossRef]
  • Lidar M, Kedem R, Mor A, Levartovsky D, Lan- gevitz P, Livneh A. Arthritis as the sole episodic manifestation of familial Mediterranean fever. J Rheumatol 2005; 32: 859-62.
  • Majeed HA, Rawashdeh M. The clinical patterns of arthritis in children with familial Mediterra- nean fever. QJM 1997; 90: 37-43. [CrossRef]
  • Ince E, Cakar N, Tekin M, Kendirli T, Ozkaya N, Akar N, et al. Arthritis in children with familial Medi- terranean fever. Rheumatol Int 2002; 21: 213-7. [CrossRef]
  • Uthman I. The arthritis of familial Mediterranean fever. J Rheumatol 2005; 32: 2278.
  • Sneh E, Pras M, Michaeli D, Shanin N, Gafni J. Pro- tracted arthritis in familial Mediterranean fever. Rheumatol Rehabil 1977; 16: 102-6.
  • Younes M, Kahn MF, Meyer O. Hip involvement in patients with familial Mediterranean fever. A review of ten cases. Joint Bone Spine 2002; 69: 560-5. [CrossRef]
  • Langevitz P, Livneh A, Zemer D, Shemer J, Pras M. Seronegative spondyloarthropathy in famil- ial Mediterranean fever. Semin Arthritis Rheum 1997; 27: 67-72. [CrossRef]
  • Cefle A, Kamali S, Sayarlioglu M, Inanc M, Ocal L, Aral O, et al. A comparison of clinical findings of familial Mediterranean fever patients with and without amyloidosis. Rheumatol Int 2005; 25: 442-6. [CrossRef]
  • Akkoc N, Gul A. Familial Mediterranean fever and seronegative arthritis. Curr Rheumatol Rep 2011; 13: 388-94. [CrossRef]
  • Akkoc N, Sari I, Akar S, Binicier O, Thomas MG, Weale ME, et al. Increased prevalence of M694V in patients with ankylosing spondylitis: additional evidence for a link with familial mediterranean fe- ver. Arthritis Rheum 2010; 62: 3059-63. [CrossRef]
  • Cosan F, Ustek D, Oku B, Duymaz-Tozkir J, Cakiris A, Abaci N, et al. Association of familial Medi- terranean fever-related MEFV variations with ankylosing spondylitis. Arthritis Rheum 2010; 62: 3232-6. [CrossRef]
  • Majeed HA, Al-Qudah AK, Qubain H, Shahin HM. The clinical patterns of myalgia in children with familial Mediterranean fever. Semin Arthri- tis Rheum 2000; 30: 138-43. [CrossRef]
  • Alayli G, Durmus D, Ozkaya O, Sen HE, Genc G, Kuru O. Frequency of juvenile fibromyalgia syn- drome in children with familial Mediterranean fever: effects on depression and quality of life. Clin Exp Rheumatol 2011; 29: S127-32.
  • Langevitz P, Buskila D, Finkelstein R, Zaks N, Neuman L, Sukenik S, et al. Fibromyalgia in fa- milial Mediterranean fever. J Rheumatol 1994; 21: 1335-7.
  • Livneh A, Langevitz P. Diagnostic and treat- ment concerns in familial Mediterranean fever. Baillieres Best Pract Res Clin Rheumatol 2000; 14: 477-98. [CrossRef]
  • Sayarlioglu M, Sayarlioglu H, Ozen S, Erkoc R, Gul A. Colchicine-induced myopathy in a teen- ager with familial Mediterranean fever. Ann Pharmacother 2003; 37: 1821-4. [CrossRef]
  • Odabas AR, Cetinkaya R, Selcuk Y, Bilen H. Famil- ial Mediterranean fever. South Med J 2002; 95: 1400-3. [CrossRef]
  • Kaplan E, Mukamel M, Barash J, Brik R, Padeh S, Berkun Y, et al. Protracted febrile myalgia in children and young adults with familial Medi- terranean fever: analysis of 15 patients and sug- gested criteria for working diagnosis. Clin Exp Rheumatol 2007; 25: S114-7.
  • Langevitz P, Zemer D, Livneh A, Shemer J, Pras M. Protracted febrile myalgia in patients with familial Mediterranean fever. J Rheumatol 1994; 21: 1708-9.
  • Kotevoglu N, Sahin F, Ozkiris SO, Bankaoglu M, Sakiz D, Kuran B. Protracted febrile myalgia of fa- milial Mediterranean fever. Clin Exp Rheumatol 2004; 22: S69-70.
  • Sidi G, Shinar Y, Livneh A, Langevitz P, Pras M, Pras E. Protracted febrile myalgia of familial Mediterranean fever. Mutation analysis and clinical correlations. Scand J Rheumatol 2000; 29: 174-6. [CrossRef]
  • Soylu A, Kasap B, Turkmen M, Saylam GS, Kavuk- cu S. Febrile myalgia syndrome in familial Medi- terranean fever. J Clin Rheumatol 2006; 12: 93-6. [CrossRef]
  • Duru NS, Civilibal M, Karakoyun M, Payasli M, Elevli M. Protracted febrile myalgia in two chil- dren with familial Mediterranean fever. Pediatr Int 2010; 52: e137-40. [CrossRef]
  • Livneh A, Langevitz P, Pras M. Pulmonary associ- ations in familial Mediterranean fever. Curr Opin Pulm Med 1999; 5: 326-31. [CrossRef]
  • Kees S, Langevitz P, Zemer D, Padeh S, Pras M, Livneh A. Attacks of pericarditis as a manifesta- tion of familial Mediterranean fever (FMF). QJM 1997; 90: 643-7. [CrossRef]
  • Dabestani A, Noble LM, Child JS, Krivokapich J, Schwabe AD. Pericardial disease in familial Mediterranean fever: an echocardiographic study. Chest 1982; 81: 592-5. [CrossRef]
  • Tutar E, Yalcinkaya F, Ozkaya N, Ekim M, Atalay S. Incidence of pericardial effusion during attacks of familial Mediterranean fever. Heart 2003; 89: 1257-8. [CrossRef]
  • Turesson C, Jacobsson LT, Matteson EL. Cardio- vascular co-morbidity in rheumatic diseases. Vasc Health Risk Manag 2008; 4: 605-14.
  • Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-9. [CrossRef]
  • Sari I, Yuksel A, Kozaci D, Selcuk S, Gokce G, Yildiz Y, et al. The effect of regular colchicine treatment on biomarkers related with vascular injury in newly diagnosed patients with familial Mediterranean fever. Inflammation 2012; 35: 1191-7. [CrossRef]
  • Terekeci HM, Ulusoy ER, Kucukarslan NM, Nalbant S, Oktenli C. Familial Mediterranean fever attacks do not alter functional and morphologic tissue Doppler echocardiographic parameters. Rheu- matol Int 2008; 28: 1239-43. [CrossRef]
  • Akdogan A, Calguneri M, Yavuz B, Arslan EB, Kalyoncu U, Sahiner L, et al. Are familial Medi- terranean fever (FMF) patients at increased risk for atherosclerosis? Impaired endothelial func- tion and increased intima media thickness are found in FMF. J Am Coll Cardiol 2006; 48: 2351-3. [CrossRef]
  • Sari I, Karaoglu O, Can G, Akar S, Gulcu A, Birlik M, et al. Early ultrasonographic markers of ath- erosclerosis in patients with familial Mediterra- nean fever. Clin Rheumatol 2007; 26: 1467-73. [CrossRef]
  • Ugurlu S, Seyahi E, Cetinkaya F, Ozbakir F, Balci H, Ozdogan H. Intima-media thickening in pa- tients with familial Mediterranean fever. Rheu- matology (Oxford) 2009; 48: 911-5. [CrossRef]
  • Langevitz P, Livneh A, Neumann L, Buskila D, Shemer J, Amolsky D, et al. Prevalence of isch- emic heart disease in patients with familial Mediterranean fever. Isr Med Assoc J 2001; 3: 9-12.
  • Nussinovitch N, Livneh A, Katz K, Nussinovitch M, Volovitz B, Lidar M, et al. P wave dispersion in familial Mediterranean fever. Rheumatol Int 2011; 31: 1591-4. [CrossRef]
  • Nussinovitch U, Ben-Zvi I, Livneh A. QT variabil- ity in amyloidosis of familial Mediterranean fe- ver. Isr Med Assoc J 2012; 14: 225-8.
  • Nussinovitch U, Kaminer K, Nussinovitch M, Volovitz B, Lidar M, Nussinovitch N, et al. QT interval variability in familial Mediterranean fever: a study in colchicine-responsive and col- chicine-resistant patients. Clin Rheumatol 2012; 31: 795-9. [CrossRef]
  • Nussinovitch U, Livneh A, Volovitz B, Nussi- novitch M, Ben-Zvi I, Lidar M, et al. Normal QT dispersion in colchicine-resistant familial Medi- terranean fever (FMF). Clin Rheumatol 2012; 31: 1093-6. [CrossRef]
  • Sari I, Arican O, Can G, Akdeniz B, Akar S, Birlik M, et al. Assessment of aortic stiffness and ventric- ular functions in familial Mediterranean fever. Anadolu Kardiyol Derg 2008; 8: 271-8.
  • Tavil Y, Ozturk MA, Ureten K, Sen N, Kaya MG, Ce- mri M, et al. Assessment of aortic wall stiffness in patients with Familial Mediterranean Fever. Joint Bone Spine 2008; 75: 280-5. [CrossRef]
  • Kalkan GY, Bayram NA, Erten S, Keles T, Durmaz T, Akcay M, et al. Evaluation of left ventricle function by strain imaging in patients with fa- milial Mediterranean fever. Echocardiography 2010; 27: 1056-60. [CrossRef]
  • Yildiz M, Masatlioglu S, Seymen P, Aytac E, Sa- hin B, Seymen HO. The carotid-femoral (aortic) pulse wave velocity as a marker of arterial stiff- ness in familial Mediterranean fever. Can J Car- diol 2006; 22: 1127-31. [CrossRef]
  • Akpolat T, Akpolat I, Karagoz F, Yilmaz E, Kan- demir B, Ozen S. Familial Mediterranean fever and glomerulonephritis and review of the liter- ature. Rheumatol Int 2004; 24: 43-5. [CrossRef]
  • Ozcakar ZB, Yuksel S, Ensari A, Ekim M, Yal- cinkaya F. Acute renal failure in a patient with familial Mediterranean fever. Rheumatol Int 2007; 27: 309-10. [CrossRef]
  • Tekin M, Yalcinkaya F, Tumer N, Cakar N, Kocak H, Oz- kaya N, et al. Familial Mediterranean fever--renal in- volvement by diseases other than amyloid. Nephrol Dial Transplant 1999; 14: 475-9. [CrossRef]
  • Barzilai A, Langevitz P, Goldberg I, Kopolovic J, Livneh A, Pras M, et al. Erysipelas-like erythema of familial Mediterranean fever: clinicopatho- logic correlation. J Am Acad Dermatol 2000; 42: 791-5. [CrossRef]
  • Akman-Demir G, Gul A, Gurol E, Ozdogan H, Bahar S, Oge AE, et al. Inflammatory/demye- linating central nervous system involvement in familial Mediterranean fever (FMF): coincidence or association? J Neurol 2006; 253: 928-34. [CrossRef]
  • Kalyoncu U, Eker A, Oguz KK, Kurne A, Kalan I, Topcuoglu AM, et al. Familial Mediterranean fe- ver and central nervous system involvement: a case series. Medicine (Baltimore) 2010; 89: 75-84. [CrossRef]
  • Yahalom G, Kivity S, Lidar M, Vaknin-Dembinsky A, Karussis D, Flechter S, et al. Familial Mediter- ranean fever (FMF) and multiple sclerosis: an association study in one of the world's largest FMF cohorts. Eur J Neurol 2011; 18: 1146-50.
  • Akalin T, Demirag MD, Tezcan ME, Ozturk MA. Scleritis and sudden hearing loss associated with familial Mediterranean fever. Clin Exp Rheumatol 2010; 28: S103-4.
  • Berestizschevsky S, Weinberger D, Avisar I, Avis- ar R. Episcleritis associated with familial Medi- terranean fever. Isr Med Assoc J 2008; 10: 318-9.
  • Yazici H, Pazarli H. Eye involvement in a patient with familial Mediterranean fever. J Rheumatol 1982; 9: 644.
  • Karalezli A, Borazan M, Yilmaz S, Kiyici H, Akova YA. Conjunctival impression cytology and tear-film changes in patients with familial Mediterranean fever. Acta Ophthalmol 2009; 87: 39-43. [CrossRef]
  • Obici L, Merlini G. Amyloidosis in autoinflamma- tory syndromes. Autoimmun Rev 2012; 12: 14-7. [CrossRef]
  • van der Hilst JC, Simon A, Drenth JP. Hereditary periodic fever and reactive amyloidosis. Clin Exp Med 2005; 5: 87-98. [CrossRef]
  • Gafni J, Ravid M, Sohar E. The role of amyloido- sis in familial mediterranean fever. A population study. Isr J Med Sci 1968; 4: 995-9.
  • Schwabe AD, Peters RS. Familial Mediterranean Fever in Armenians. Analysis of 100 cases. Med- icine (Baltimore) 1974; 53: 453-62. [CrossRef]
  • Touitou I, Sarkisian T, Medlej-Hashim M, Tunca M, Livneh A, Cattan D, et al. Country as the pri- mary risk factor for renal amyloidosis in familial Mediterranean fever. Arthritis Rheum 2007; 56: 1706-12. [CrossRef]
  • Saatci U, Ozen S, Ozdemir S, Bakkaloglu A, Bes- bas N, Topaloglu R, et al. Familial Mediterranean fever in children: report of a large series and discussion of the risk and prognostic factors of amyloidosis. Eur J Pediatr 1997; 156: 619-23. [CrossRef]
  • Sungur C, Sungur A, Ruacan S, Arik N, Yasavul U, Turgan C, et al. Diagnostic value of bone mar- row biopsy in patients with renal disease sec- ondary to familial Mediterranean fever. Kidney Int 1993; 44: 834-6. [CrossRef]
  • Tishler M, Pras M, Yaron M. Abdominal fat tissue aspirate in amyloidosis of familial Mediterra- nean fever. Clin Exp Rheumatol 1988; 6: 395-7.
  • Soriano A, Manna R. Familial Mediterranean fever: new phenotypes. Autoimmun Rev 2012; 12: 31-7. [CrossRef]
  • Aksu K, Keser G. Coexistence of vasculitides with familial Mediterranean fever. Rheumatol Int 2011; 31: 1263-74. [CrossRef]
  • Ozen S, Ben-Chetrit E, Bakkaloglu A, Gur H, Ti- naztepe K, Calguneri M, et al. Polyarteritis no- dosa in patients with Familial Mediterranean Fever (FMF): a concomitant disease or a feature of FMF? Semin Arthritis Rheum 2001; 30: 281-7. [CrossRef]
  • Hatemi G, Masatlioglu S, Gogus F, Ozdogan H. Necrotizing vasculitis associated with familial Mediterranean fever. Am J Med 2004; 117: 516-9. [CrossRef]
  • Ozdogan H, Arisoy N, Kasapcapur O, Sever L, Cal- iskan S, Tuzuner N, et al. Vasculitis in familial Med- iterranean fever. J Rheumatol 1997; 24: 323-7.
  • Yazici Y, Yurdakul S, Yazici H. Behcet's syndrome. Curr Rheumatol Rep 2010; 12: 429-35. [CrossRef]
  • Schwartz T, Langevitz P, Zemer D, Gazit E, Pras M, Livneh A. Behcet's disease in Familial Medi- terranean fever: characterization of the associa- tion between the two diseases. Semin Arthritis Rheum 2000; 29: 286-95. [CrossRef]
  • Yurdakul S, Gunaydin I, Tuzun Y, Tankurt N, Pazarli H, Ozyazgan Y, et al. The prevalence of Behcet's syndrome in a rural area in northern Turkey. J Rheumatol 1988; 15: 820-2.
  • Ben-Chetrit E, Levy M. Reproductive system in familial Mediterranean fever: an overview. Ann Rheum Dis 2003; 62: 916-9. [CrossRef]
  • Mijatovic V, Hompes PG, Wouters MG. Familial Mediterranean fever and its implications for fertility and pregnancy. Eur J Obstet Gynecol Reprod Biol 2003; 108: 171-6. [CrossRef]
  • Cerquaglia C, Verrecchia E, Fonnesu C, Giovinale G, Marinaro A, de Socio G, et al. Female repro- ductive dysfunction in familial Mediterranean fever patients with and without colchicine treatment. Clin Exp Rheumatol 2010; 28: S101.
  • Ofir D, Levy A, Wiznitzer A, Mazor M, Sheiner E. Familial Mediterranean fever during pregnancy: an independent risk factor for preterm delivery. Eur J Obstet Gynecol Reprod Biol 2008; 141: 115-8. [CrossRef]
  • Ismajovich B, Zemer D, Revach M, Serr DM, Sohar E. The causes of sterility in females with familial Mediterranean fever. Fertil Steril 1973; 24: 844-7.
  • Ehrenfeld M, Brzezinski A, Levy M, Eliakim M. Fertility and obstetric history in patients with familial Mediterranean fever on long-term col- chicine therapy. Br J Obstet Gynaecol 1987; 94: 1186-91. [CrossRef]
  • Dotters-Katz S, Kuller J, Price T. The impact of fa- milial Mediterranean fever on women's health. Obstet Gynecol Surv 2012; 67: 357-64. [CrossRef]
  • Cabili S, Livneh A, Zemer D, Rabinovitch O, Pras M. The effect of pregnancy on renal function in amyloidosis of familial Mediterranean fever. Am J Reprod Immunol 1992; 28: 243-4. [CrossRef]
  • Livneh A, Cabili S, Zemer D, Rabinovitch O, Pras M. Effect of pregnancy on renal function in amyloidosis of familial Mediterranean fever. J Rheumatol 1993; 20: 1519-23.
  • Nabil H, Zayed A, State O, Badawy A. Pregnancy outcome in women with familial Mediterra- nean fever. J Obstet Gynaecol 2012; 32: 756-9. [CrossRef]
  • Hansteen IL. Colchicine and chromosome aber- rations. Lancet 1969; 2: 744-5. [CrossRef]
  • Amoura Z, Schermann JM, Wechsler B, Zerah X, Goodeau P. Transplacental passage of colchi- cine in familial Mediterranean fever. J Rheuma- tol 1994; 21: 383.
  • Ben-Chetrit E, Ben-Chetrit A, Berkun Y. Pregnan- cy outcomes in women with familial Mediterra- nean fever receiving colchicine: is amniocente- sis justified? Arthritis Care Res (Hoboken) 2010; 62: 143-8. [CrossRef]
  • Berkenstadt M, Weisz B, Cuckle H, Di-Castro M, Guetta E, Barkai G. Chromosomal abnormalities and birth defects among couples with colchi- cine treated familial Mediterranean fever. Am J Obstet Gynecol 2005; 193: 1513-6. [CrossRef]
  • Diav-Citrin O, Shechtman S, Schwartz V,
  • Dinarello CA, Wolff SM, Goldfinger SE, Dale DC,
  • Avgil-Tsadok M, Finkel-Pekarsky V, Wajnberg R,
  • et al. Pregnancy outcome after in utero expo
  • sure to colchicine. Am J Obstet Gynecol 2010; 203: 144.e1-6.
  • Andreu JM, Timasheff SN. Interaction of tubulin with single ring analogues of colchicine. Bio- chemistry 1982; 21: 534-43. [CrossRef]
  • Ben-Chetrit E, Berkun Y, Ben-Chetrit A. The out- come of pregnancy in the wives of men with familial mediterranean fever treated with col- chicine. Semin Arthritis Rheum 2004; 34: 549-52. [CrossRef]
  • Ben-Chetrit E, Scherrmann JM, Levy M. Col- chicine in breast milk of patients with familial Mediterranean fever. Arthritis Rheum 1996; 39: 1213-7. [CrossRef]
  • Milunsky JM. Breast-feeding during colchicine therapy for familial Mediterranean fever. J Pedi- atr 1991; 119: 164. [CrossRef]
  • Makay B, Unsal E. Does breast-feeding affect severity of familial Mediterranean fever? Clin Rheumatol 2009; 28: 1389-93. [CrossRef]
  • Pras M. Familial Mediterranean fever: from the clinical syndrome to the cloning of the pyrin gene. Scand J Rheumatol 1998; 27: 92-7. [CrossRef]
  • Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1997; 40: 1879-85. [CrossRef]
  • Korkmaz C, Ozdogan H, Kasapcopur O, Yazici H. Acute phase response in familial Mediterranean fever. Ann Rheum Dis 2002; 61: 79-81. [CrossRef]
  • Lachmann HJ, Sengul B, Yavuzsen TU, Booth DR, Booth SE, Bybee A, et al. Clinical and subclinical inflammation in patients with familial Mediter- ranean fever and in heterozygous carriers of MEFV mutations. Rheumatology (Oxford) 2006; 45: 746-50. [CrossRef]
  • Duzova A, Bakkaloglu A, Besbas N, Topaloglu R, Ozen S, Ozaltin F, et al. Role of A-SAA in mon- itoring subclinical inflammation and in colchi- cine dosage in familial Mediterranean fever. Clin Exp Rheumatol 2003; 21: 509-14.
  • Tunca M, Kirkali G, Soyturk M, Akar S, Pepys MB, Hawkins PN. Acute phase response and evo- lution of familial Mediterranean fever. Lancet 1999; 353: 1415. [CrossRef]
  • Manukyan GP, Ghazaryan KA, Ktsoyan Zh A, Tatyan MV, Khachatryan ZA, Hakobyan GS, et al. Cytokine profile of Armenian patients with Familial Mediterra- nean fever. Clin Biochem 2008; 41: 920-2. [CrossRef]
  • Oktem S, Yavuzsen TU, Sengul B, Akhunlar H, Akar S, Tunca M. Levels of interleukin-6 (IL-6) and its soluble receptor (sIL-6R) in familial Mediterra- nean fever (FMF) patients and their first degree relatives. Clin Exp Rheumatol 2004; 22: S34-6.
  • Ceri M, Unverdi S, Altay M, Ureten K, Ozturk MA, Gonen N, et al. Anti-cyclic citrullinated peptides positivity rate in patients with familial Mediterra- nean fever. Clin Exp Rheumatol 2010; 28: S58-61.
  • Guler E, Kaptanoglu E, Sahin O, Candan F, Hayta E, Elden H. Autoantibodies are not associated with familial mediterranean fever. Acta Reuma- tol Port 2012; 37: 144-8.
  • Korkmaz C, Kasifoglu T. Changes in the liver function tests during the attacks of familial Med- iterranean fever. Rheumatol Int 2007; 27: 395-8. [CrossRef] Alling DW. Colchicine therapy for familial med- iterranean fever. A double-blind trial. N Engl J Med 1974; 291: 934-7. [CrossRef]
  • Zemer D, Revach M, Pras M, Modan B, Schor S, Sohar E, et al. A controlled trial of colchicine in preventing attacks of familial mediterranean fe- ver. N Engl J Med 1974; 291: 932-4. [CrossRef]
  • Goldstein RC, Schwabe AD. Prophylactic colchi- cine therapy in familial Mediterranean fever. A controlled, double-blind study. Ann Intern Med 1974; 81: 792-4. [CrossRef]
  • Ozturk MA, Kanbay M, Kasapoglu B, Onat AM, Guz G, Furst DE, et al. Therapeutic approach to familial Mediterranean fever: a review update. Clin Exp Rheumatol 2011; 29: S77-86.
  • Majeed HA, Barakat M. Familial Mediterranean fever (recurrent hereditary polyserositis) in chil- dren: analysis of 88 cases. Eur J Pediatr 1989; 148: 636-41. [CrossRef]
  • Zemer D, Livneh A, Danon YL, Pras M, Sohar E. Long-term colchicine treatment in children with familial Mediterranean fever. Arthritis Rheum 1991; 34: 973-7. [CrossRef]
  • Ben-Chetrit E, Ozdogan H. Non-response to colchicine in FMF--definition, causes and sug- gested solutions. Clin Exp Rheumatol 2008; 26: S49-51.
  • Kallinich T, Haffner D, Niehues T, Huss K, Lainka E, Neudorf U, et al. Colchicine use in children and adolescents with familial Mediterranean fe- ver: literature review and consensus statement. Pediatrics 2007; 119: e474-83. [CrossRef]
  • Livneh A, Zemer D, Langevitz P, Laor A, Sohar E, Pras M. Colchicine treatment of AA amyloido- sis of familial Mediterranean fever. An analysis of factors affecting outcome. Arthritis Rheum 1994; 37: 1804-11. [CrossRef]
  • Zemer D, Livneh A, Langevitz P. Reversal of the nephrotic syndrome by colchicine in amyloido- sis of familial Mediterranean fever. Ann Intern Med 1992; 116: 426. [CrossRef]
  • Ben-Chetrit E, Levy M. Familial Mediterranean fever. Lancet 1998; 351: 659-64. [CrossRef]
  • Erken E, Ozer HT, Bozkurt B, Gunesacar R, Erken EG, Dinkci S. Early suppression of familial Medi- terranean fever attacks by single medium dose methyl-prednisolone infusion. Joint Bone Spine 2008; 75: 370-2. [CrossRef]
  • Tunca M, Akar S, Soyturk M, Kirkali G, Resmi H, Akhunlar H, et al. The effect of interferon al- pha administration on acute attacks of familial Mediterranean fever: A double-blind, place- bo-controlled trial. Clin Exp Rheumatol 2004; 22: S37-40.
  • Ozen S, Bilginer Y, Aktay Ayaz N, Calguneri M. Anti-interleukin 1 treatment for patients with familial Mediterranean fever resistant to colchi- cine. J Rheumatol 2011; 38: 516-8. [CrossRef]
  • Meinzer U, Quartier P, Alexandra JF, Hentgen V, Retornaz F, Kone-Paut I. Interleukin-1 targeting drugs in familial Mediterranean fever: a case se- ries and a review of the literature. Semin Arthri- tis Rheum 2011; 41: 265-71. [CrossRef]
  • Hashkes PJ, Spalding SJ, Giannini EH, Huang B, Johnson A, Park G, et al. Rilonacept for colchi- cine-resistant or -intolerant familial Mediterra- nean fever: a randomized trial. Ann Intern Med 2012; 157: 533-41. [CrossRef]
  • Ozgocmen S, Akgul O. Anti-TNF agents in famil- ial Mediterranean fever: report of three cases and review of the literature. Mod Rheumatol 2011; 21: 684-90. [CrossRef]
  • Seyahi E, Ozdogan H, Celik S, Ugurlu S, Yazici H. Treatment options in colchicine resistant famil- ial Mediterranean fever patients: thalidomide and etanercept as adjunctive agents. Clin Exp Rheumatol 2006; 24: S99-103.
APA Sari I, Birlik M, KAŞİFOĞLU T (2014). Familial Mediterranean fever: An updated review. , 21 - 33.
Chicago Sari Ismail,Birlik Merih,KAŞİFOĞLU Timuçin Familial Mediterranean fever: An updated review. (2014): 21 - 33.
MLA Sari Ismail,Birlik Merih,KAŞİFOĞLU Timuçin Familial Mediterranean fever: An updated review. , 2014, ss.21 - 33.
AMA Sari I,Birlik M,KAŞİFOĞLU T Familial Mediterranean fever: An updated review. . 2014; 21 - 33.
Vancouver Sari I,Birlik M,KAŞİFOĞLU T Familial Mediterranean fever: An updated review. . 2014; 21 - 33.
IEEE Sari I,Birlik M,KAŞİFOĞLU T "Familial Mediterranean fever: An updated review." , ss.21 - 33, 2014.
ISNAD Sari, Ismail vd. "Familial Mediterranean fever: An updated review". (2014), 21-33.
APA Sari I, Birlik M, KAŞİFOĞLU T (2014). Familial Mediterranean fever: An updated review. European Journal of Rheumatology, 1(1), 21 - 33.
Chicago Sari Ismail,Birlik Merih,KAŞİFOĞLU Timuçin Familial Mediterranean fever: An updated review. European Journal of Rheumatology 1, no.1 (2014): 21 - 33.
MLA Sari Ismail,Birlik Merih,KAŞİFOĞLU Timuçin Familial Mediterranean fever: An updated review. European Journal of Rheumatology, vol.1, no.1, 2014, ss.21 - 33.
AMA Sari I,Birlik M,KAŞİFOĞLU T Familial Mediterranean fever: An updated review. European Journal of Rheumatology. 2014; 1(1): 21 - 33.
Vancouver Sari I,Birlik M,KAŞİFOĞLU T Familial Mediterranean fever: An updated review. European Journal of Rheumatology. 2014; 1(1): 21 - 33.
IEEE Sari I,Birlik M,KAŞİFOĞLU T "Familial Mediterranean fever: An updated review." European Journal of Rheumatology, 1, ss.21 - 33, 2014.
ISNAD Sari, Ismail vd. "Familial Mediterranean fever: An updated review". European Journal of Rheumatology 1/1 (2014), 21-33.
Sayfa Oluşturulma Tarihi
17-04-2024 5:17

İLETİŞİM

TÜBİTAK ULAKBİM TR Dizin

Yüzüncüyıl, İşçi Blokları Mahallesi

Muhsin Yazıcıoğlu Caddesi No:51/C

06530 Çankaya / ANKARA +90 (312) 298 92 00

trdizin@tubitak.gov.tr

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © Tüm Hakları Saklıdır. Gizlilik Politikası Kullanım Şartları